Oncogenic deletion mutants of gp130 signal from intracellular compartments

Journal of Cell Science

Volumn 127, Issue 2, 2014, Pages 341-353

  Schmidt Arras, Dirk ^a   Müller, Miryam ^a   Stevanovic, Marija ^a   Horn, Silke ^a   Schütt, Antje ^a   Bergmann, Juri ^b   Wilkens, Ruven ^a   Lickert, Annett ^a   Rose John, Stefan ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Endoplasmic reticulum; Endosome; ER; Glycoprotein 130; Gp130; IHCA; IL 6; Inflammatory hepatocellular adenoma; Interleukin 6

Indexed keywords

CALNEXIN; GLYCOPROTEIN GP 130; STAT3 PROTEIN;

ANIMAL CELL; ARTICLE; CELL COMPARTMENTALIZATION; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; DELETION MUTANT; ENDOPLASMIC RETICULUM; ENDOSOME; FIBROBLAST; GLYCOSYLATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ENDOPLASMIC RETICULUM; ENDOSOME; ER; GLYCOPROTEIN 130; GP130; IHCA; IL-6; INFLAMMATORY HEPATOCELLULAR ADENOMA; INTERLEUKIN 6;

ANIMALS; CELL COMPARTMENTATION; CYTOKINE RECEPTOR GP130; ENDOPLASMIC RETICULUM; ENDOSOMES; FEEDBACK, PHYSIOLOGICAL; HEK293 CELLS; HEP G2 CELLS; HUMANS; INTRACELLULAR SPACE; MICE; MODELS, BIOLOGICAL; NEOPLASMS; PROTEIN TRANSPORT; SEQUENCE DELETION; SIGNAL TRANSDUCTION; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

EID: 84892555997     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.130294     Document Type: Article

References (41)

1. Albino, A. P., Lloyd, K. O., Ikeda, H. and Old, L. J. (1983). Biochemical analysis of a 130,000 molecular weight glycoprotein on human melanoma cells. J. Immunol. 131, 1595-1599.
2. Bioulac-Sage, P., Blanc, J. F., Rebouissou, S., Balabaud, C. and Zucman-Rossi, J. (2007). Genotype phenotype classification of hepatocellular adenoma. World J. Gastroenterol. 13, 2649-2654.
3. Bolte, S. and Cordelières, F. P. (2006). A guided tour into subcellular colocalization analysis in light microscopy. J. Microsc. 224, 213-232.
4. Boncompain, G., Divoux, S., Gareil, N., de Forges, H., Lescure, A., Latreche, L., Mercanti, V., Jollivet, F., Raposo, G. and Perez, F. (2012). Synchronization of secretory protein traffic in populations of cells. Nat. Methods 9, 493-498.
5. Brodsky, J. L. (2012). Cleaning up: ER-associated degradation to the rescue. Cell 151, 1163-1167.
6. Brodsky, J. L. and Skach, W. R. (2011). Protein folding and quality control in the endoplasmic reticulum: Recent lessons from yeast and mammalian cell systems. Curr. Opin. Cell Biol. 23, 464-475.
7. Connerly, P. L., Esaki, M., Montegna, E. A., Strongin, D. E., Levi, S., Soderholm, J. and Glick, B. S. (2005). Sec16 is a determinant of transitional ER organization. Curr. Biol. 15, 1439-1447.
8. Dittrich, E., Haft, C. R., Muys, L., Heinrich, P. C. and Graeve, L. (1996). A di-leucine motif and an upstream serine in the interleukin-6 (IL-6) signal transducer gp130 mediate ligand-induced endocytosis and down-regulation of the IL-6 receptor. J. Biol. Chem. 271, 5487-5494.
9. Fischer, M., Goldschmitt, J., Peschel, C., Brakenhoff, J. P., Kallen, K. J., Wollmer, A., Grötzinger, J. and Rose-John, S. (1997). I. A bioactive designer cytokine for human hematopoietic progenitor cell expansion. Nat. Biotechnol. 15, 142-145.
10. Gearing, D. P., Ziegler, S. F., Comeau, M. R., Friend, D., Thoma, B., Cosman, D., Park, L. and Mosley, B. (1994). Proliferative responses and binding properties of hematopoietic cells transfected with low-affinity receptors for leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor. Proc. Natl. Acad. Sci. USA 91, 1119-1123.
11. Gerhartz, C., Dittrich, E., Stoyan, T., Rose-John, S., Yasukawa, K., Heinrich, P. C. and Graeve, L. (1994). Biosynthesis and half-life of the interleukin-6 receptor and its signal transducer gp130. Eur. J. Biochem. 223, 265-274.
12. Grivennikov, S. and Karin, M. (2008). Autocrine IL-6 signaling: a key event in tumorigenesis? Cancer Cell 13, 7-9.
13. Gu, Z. J., Wijdenes, J., Zhang, X. G., Hallet, M. M., Clement, C. and Klein, B. (1996). Anti-gp130 transducer monoclonal antibodies specifically inhibiting ciliary neurotrophic factor, interleukin-6, interleukin-11, leukemia inhibitory factor or oncostatin M. J. Immunol. Methods 190, 21-27.
14. Haan, C., Heinrich, P. C. and Behrmann, I. (2002). Structural requirements of the interleukin-6 signal transducer gp130 for its interaction with Janus kinase 1: the receptor is crucial for kinase activation. Biochem. J. 361, 105-111.
15. Heinrich, P. C., Behrmann, I., Haan, S., Hermanns, H. M., Müller-Newen, G. and Schaper, F. (2003). Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem. J. 374, 1-20.
16. Hetz, C. and Glimcher, L. H. (2009). Fine-tuning of the unfolded protein response: Assembling the IRE1alpha interactome. Mol. Cell 35, 551-561.
17. Ihara, Y., Cohen-Doyle, M. F., Saito, Y. and Williams, D. B. (1999). Calnexin discriminates between protein conformational states and functions as a molecular chaperone in vitro. Mol. Cell 4, 331-341.
18. Iinuma, T., Shiga, A., Nakamoto, K., O'Brien, M. B., Aridor, M., Arimitsu, N., Tagaya, M. and Tani, K. (2007). Mammalian Sec16/p250 plays a role in membrane traffic from the endoplasmic reticulum. J. Biol. Chem. 282, 17632-17639.
19. Joffre, C., Barrow, R., Ménard, L., Calleja, V., Hart, I. R. and Kermorgant, S. (2011). A direct role for Met endocytosis in tumorigenesis. Nat. Cell Biol. 13, 827-837.
20. Jousset, C., Carron, C., Boureux, A., Quang, C. T., Oury, C., Dusanter-Fourt, I., Charon, M., Levin, J., Bernard, O. and Ghysdael, J. (1997). A domain of TEL conserved in a subset of ETS proteins defines a specific oligomerization interface essential to the mitogenic properties of the TEL-PDGFR beta oncoprotein. EMBO J. 16, 69-82.
21. Kallen, K. J., Grötzinger, J. and Rose-John, S. (2000). New perspectives on the design of cytokines and growth factors. Trends Biotechnol. 18, 455-461.
22. Meister, S., Schubert, U., Neubert, K., Herrmann, K., Burger, R., Gramatzki, M., Hahn, S., Schreiber, S., Wilhelm, S., Herrmann, M. et al. (2007). Extensive immunoglobulin production sensitizes myeloma cells for proteasome inhibition. Cancer Res. 67, 1783-1792.
23. Pearse, B. R., Gabriel, L., Wang, N. and Hebert, D. N. (2008). A cell-based reglucosylation assay demonstrates the role of GT1 in the quality control of a maturing glycoprotein. J. Cell Biol. 181, 309-320.
24. Pilati, C., Amessou, M., Bihl, M. P., Balabaud, C., Nhieu, J. T. V., Paradis, V., Nault, J. C., Izard, T., Bioulac-Sage, P., Couchy, G. et al. (2011). Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas. J. Exp. Med. 208, 1359-1366.
25. Rebouissou, S., Amessou, M., Couchy, G., Poussin, K., Imbeaud, S., Pilati, C., Izard, T., Balabaud, C., Bioulac-Sage, P. and Zucman-Rossi, J. (2009). Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours. Nature 457, 200-204.
26. Scheller, J., Chalaris, A., Schmidt-Arras, D. and Rose-John, S. (2011). The pro-and anti-inflammatory properties of the cytokine interleukin-6. Biochim. Biophys. Acta 1813, 878-888.
27. Schmidt-Arras, D. E., Böhmer, A., Markova, B., Choudhary, C., Serve, H. and Böhmer, F. D. (2005). Tyrosine phosphorylation regulates maturation of receptor tyrosine kinases. Mol. Cell. Biol. 25, 3690-3703.
28. Schmidt-Arras, D., Böhmer, S. A., Koch, S., Müller, J. P., Blei, L., Cornils, H., Bauer, R., Korasikha, S., Thiede, C. and Böhmer, F. D. (2009). Anchoring of FLT3 in the endoplasmic reticulum alters signaling quality. Blood 113, 3568-3576.
29. Schmitz, J., Weissenbach, M., Haan, S., Heinrich, P. C. and Schaper, F. (2000). SOCS3 exerts its inhibitory function on interleukin-6 signal transduction through the SHP2 recruitment site of gp130. J. Biol. Chem. 275, 12848-12856.
30. Schütt, A., Zacharias, M., Schneider, N., Horn, S., Grötzinger, J., Rose-John, S. and Schmidt-Arras, D. (2013). gp130 activation is regulated by D2-D3 interdomain connectivity. Biochem. J. 450, 487-496.
31. Shah, M., Patel, K., Mukhopadhyay, S., Xu, F., Guo, G. and Sehgal, P. B. (2006). Membrane-associated STAT3 and PY-STAT3 in the cytoplasm. J. Biol. Chem. 281, 7302-7308.
32. Sommer, J., Effenberger, T., Volpi, E., Waetzig, G. H., Bernhardt, M., Suthaus, J., Garbers, C., Rose-John, S., Floss, D. M. and Scheller, J. (2012). Constitutively active mutant gp130 receptor protein from inflammatory hepatocellular adenoma is inhibited by an anti-gp130 antibody that specifically neutralizes interleukin 11 signaling. J. Biol. Chem. 287, 13743-13751.
33. Taylor, S. C., Ferguson, A. D., Bergeron, J. J. M. and Thomas, D. Y. (2004). The ER protein folding sensor UDP-glucose glycoprotein-glucosyltransferase modifies substrates distant to local changes in glycoprotein conformation. Nat. Struct. Mol. Biol. 11, 128-134.
34. Taylor, M. J., Perrais, D. and Merrifield, C. J. (2011). A high precision survey of the molecular dynamics of mammalian clathrin-mediated endocytosis. PLoS Biol. 9, e1000604.
35. Thiel, S., Behrmann, I., Dittrich, E., Muys, L., Tavernier, J., Wijdenes, J., Heinrich, P. C. and Graeve, L. (1998). Internalization of the interleukin 6 signal transducer gp130 does not require activation of the Jak/STAT pathway. Biochem. J. 330, 47-54.
36. Thiem, S., Pierce, T. P., Palmieri, M., Putoczki, T. L., Buchert, M., Preaudet, A., Farid, R. O., Love, C., Catimel, B., Lei, Z. et al. (2013). mTORC1 inhibition restricts inflammation-associated gastrointestinal tumorigenesis in mice. J. Clin. Invest. 123, 767-781.
37. Uecker, A., Sicker, M., Beckers, T., Mahboobi, S., Hägerstrand, D., Ostman, A. and Böhmer, F. D. (2010). Chimeric tyrosine kinase-HDAC inhibitors as antiproliferative agents. Anticancer Drugs 21, 759-765.
38. Vassilakos, A., Cohen-Doyle, M. F., Peterson, P. A., Jackson, M. R. and Williams, D. B. (1996). The molecular chaperone calnexin facilitates folding and assembly of class I histocompatibility molecules. EMBO J. 15, 1495-1506.
39. Ware, F. E., Vassilakos, A., Peterson, P. A., Jackson, M. R., Lehrman, M. A. and Williams, D. B. (1995). The molecular chaperone calnexin binds Glc1Man9GlcNAc2 oligosaccharide as an initial step in recognizing unfolded glycoproteins. J. Biol. Chem. 270, 4697-4704.
40. Witte, K., Schuh, A. L., Hegermann, J., Sarkeshik, A., Mayers, J. R., Schwarze, K., Yates, J. R., 3rd, Eimer, S. and Audhya, A. (2011). TFG-1 function in protein secretion and oncogenesis. Nat. Cell Biol. 13, 550-558.
41. Xu, F., Mukhopadhyay, S. and Sehgal, P. B. (2007). Live cell imaging of interleukin-6-induced targeting of "transcription factor" STAT3 to sequestering endosomes in the cytoplasm. Am. J. Physiol. 293, C1374-C1382.